|
Utilization and cost of diabetes testing supplies by Type of Diabetes and Treatment, Saskatchewan 2001 |
||||||
| Number of Cases |
Number (%) of Subjects with ≥ 1 record for testing supplies |
Average (SD) Number of Records |
Average (SD) DP share (Can$) |
Average (SD) Patient Share (Can$) |
Average (SD)A, B Total (Can$) |
|
|
|
||||||
| Type 1 |
4005 |
3143 (78.5) |
5.8 (6.4) |
231.71 (408.53)A |
240.60 (343.81)A |
472.31 (560.75)A |
| (% of Total) |
(9.6%) |
(49.1%) |
(50.9%) |
|||
| Type 2 |
||||||
| No medication |
14157 |
3169 (22.4%) |
0.5 (1.5) |
11.78 (62.14)B |
23.69 (72.61)B |
35.47 (107.22)B |
| (% of Type 2) |
(37.6%) |
(33.2%) |
(66.8%) |
|||
| Oral anti-diabetic agent only |
18910 |
11814 (62.5) |
2.0 (2.6) |
57.78 (132.42) |
73.42 (110.65) |
131.21 (189.78) |
| (% of Type 2) |
(50.3%) |
(44.0%) |
(56.0%) |
|||
| Insulin only |
2212 |
1751 (79.2) |
4.6 (5.0) |
194.53 (296.40) |
153.33 (233.26) |
347.86 (409.39) |
| (% of Type 2) |
(5.9%) |
(55.9%) |
(44.1%) |
|||
| Insulin and oral anti-diabetic agent |
2346 |
2037 (86.8) |
4.9 (4.4) |
220.08 (286.55) |
148.48 (187.50) |
368.56 (362.67) |
| (% of Type 2) |
(6.2%) |
(59.7%) |
(40.3%) |
|||
| Type 2 Total |
37625 |
18771 (49.9) |
1.8 (2.9) |
58.63 (155.18)A |
64.09 (122.86)A |
122.72 (233.88)A |
| (% of Total) |
(90.4%) |
(47.8%) |
(52.2%) |
|||
|
A p < 0.001 between type 1 and type 2 diabetes using the Kruskal Wallis Test B p < 0.001 between treatment groups within type 2 diabetes (i.e. no medication, oral anti-diabetic agent only, insulin only, insulin and oral anti-diabetic agent) using the Kruskal Wallis Test | ||||||
Johnson et al. BMC Health Services Research 2006 6:159 doi:10.1186/1472-6963-6-159 |
||||||